X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Aventis Pharma Fact Sheet, Aventis Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aventis Pharma Fact Sheet   (HOCM)

Here is the latest financial fact sheet of Aventis Pharma. For more details, see the Aventis Pharma quarterly results and Aventis Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SANOFI INDIA Price History

Price Rs 5,572.0
Mkt Cap Rs m 128,323
Vol '000 0.2
P/E X 36.8
P/CF X 30.0
EPS (TTM) Rs 151.3
% ch % 1.6
No. of shares m 23.03
% ch week % 1.1
% ch 1-mth % 6.5
% ch 12-mth % 30.0
52 week H/L Rs 5,995.0/3,901.0
(As on Jul 23, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SANOFI INDIA Financials

No. of Mths
Year Ending
12
Dec-12
12
Dec-13
12
Dec-14
12
Dec-15
12
Dec-16
5-Yr Chart
Click to enlarge
SANOFI INDIA EQUITY SHARE DATA
High Rs2,3992,8623,8004,5214,560 
Low Rs2,1962,4502,5003,4454,400 
Sales per share (Unadj.) Rs683.0785.4858.7952.31,028.5 
Earnings per share (Unadj.) Rs76.7115.1114.5139.6129.0 
Diluted earnings per shareRs76.7115.1114.5139.6129.0 
Cash flow per share (Unadj.) Rs115.7155.2156.4188.7186.0 
Dividends per share (Unadj.) Rs33.0045.0045.0065.0068.00 
Adj. dividends per shareRs33.0045.0045.0065.0068.00 
Dividend yield (eoy) %1.41.71.41.61.5 
Book value per share (Unadj.) Rs522.8584.8645.2706.5753.6 
Adj. book value per shareRs522.8584.8645.2706.5753.6 
Shares outstanding (eoy) m23.0323.0323.0323.0323.03 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.43.43.74.24.4 
Avg P/E ratio x30.023.127.528.534.7 
P/CF ratio (eoy) x19.917.120.121.124.1 
Price / Book Value ratio x4.44.54.95.65.9 
Dividend payout %43.039.139.346.652.7 
Avg Mkt Cap Rs m52,91161,16872,54591,724103,174 
No. of employees `0003.23.33.43.73.6 
Total wages/salary Rs m2,1382,4212,8823,3333,592 
Avg. sales/employee Rs Th4,971.75,496.45,735.25,987.06,537.7 
Avg. wages/employee Rs Th675.7735.7836.0909.9991.4 
Avg. net profit/employee Rs Th558.3805.8764.5877.7819.8 
SANOFI INDIA INCOME DATA
Net Sales Rs m15,73018,08919,77521,93023,686 
Other income Rs m412579643514708 
Total revenues Rs m16,14218,66720,41822,44424,394 
Gross profit Rs m3,1183,9793,3894,5915,281 
Depreciation Rs m8999239661,1301,313 
Interest Rs m1445415 
Profit before tax Rs m2,6173,6313,0613,9704,661 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m02546668390 
Tax Rs m8511,2331,0901,5941,691 
Profit after tax Rs m1,7672,6522,6363,2152,970 
Gross profit margin %19.822.017.120.922.3 
Effective tax rate %32.534.035.640.136.3 
Net profit margin %11.214.713.314.712.5 
SANOFI INDIA BALANCE SHEET DATA
Current assets Rs m8,2879,47112,62812,43715,673 
Current liabilities Rs m3,8664,6896,5586,1706,678 
Net working cap to sales %28.126.430.728.638.0 
Current ratio x2.12.01.92.02.3 
Inventory Days Days6369888076 
Debtors Days Days2324212422 
Net fixed assets Rs m7,4288,3488,5828,7718,098 
Share capital Rs m230230230230230 
"Free" reserves Rs m11,66513,09914,55916,00417,088 
Net worth Rs m12,04113,46714,85816,27217,356 
Long term debt Rs m00000 
Total assets Rs m16,31318,78322,27624,04625,400 
Interest coverage x187.9865.5638.6993.5311.7 
Debt to equity ratio x00000 
Sales to assets ratio x1.01.00.90.90.9 
Return on assets %10.914.111.913.411.8 
Return on equity %14.719.717.719.817.1 
Return on capital %21.928.925.129.626.9 
Exports to sales %15.623.024.224.224.5 
Imports to sales %27.530.236.926.128.0 
Exports (fob) Rs m2,4474,1524,7885,3125,801 
Imports (cif) Rs m4,3265,4557,2985,7206,627 
Fx inflow Rs m3,2034,8655,4956,6807,145 
Fx outflow Rs m4,8656,0948,0456,5876,846 
Net fx Rs m-1,662-1,229-2,55093299 
SANOFI INDIA CASH FLOW
From Operations Rs m 2,898 2,726 2,650 2,132 3,226 
From Investments Rs m -54 -3,354 613 359 -1,555 
From Financial Activity Rs m -897 -1,050 -1,217 -1,470 -1,818 
Net Cashflow Rs m 1,946 -1,678 2,046 1,021 -147 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 60.4%
Indian inst/Mut Fund 14.4%
FIIs 14.6%
ADR/GDR 0.0%
Free float 10.5%
Shareholders 15,184
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Aventis House, 54/A, Mathuradas Vasanji Road, Andheri (E), Mumbai-93
E-MAIL k.subramani@sanofi.com WEB www.sanofiindialtd.com
TELEPHONE (022) 2827 8000 FAX (022) 2837 0939
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR S. R. Batliboi & Co.
CHM: Vijay Mallya COMP SEC: K. Subramani YEAR OF INC: 1956 BSE CODE: 500674 FV (Rs): 10 DIV YIELD (%): 1.2

More Pharmaceuticals Company Fact Sheets:   ALEMBIC PHARMA  WYETH LTD  PLETHICO PHARMA  AMAR REMEDIES  TTK HEALTHCARE  

Compare SANOFI INDIA With:   ALEMBIC PHARMA  WYETH LTD  PLETHICO PHARMA  AMAR REMEDIES  TTK HEALTHCARE  

Compare SANOFI INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 222 Points Higher; Telecom and FMCG Stocks Witness Buying(Closing)

Indian share markets continued their momentum and ended the day on a positive note today. Gains were largely seen in the telecom sector and FMCG sector.

Views on news

SANOFI INDIA Announces Quarterly Results (4QFY18); Net Profit Up 37.5% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SANOFI INDIA has posted a net profit of Rs 825 m (up 37.5% YoY). Sales on the other hand came in at Rs 6 bn (up 11.7% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA - TEVA PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS